|
Match
|
Document |
Document Title |
|
|
5972975 |
Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
Substituted 2-aminopyridine compounds of Formula (I) and pharmaceutically acceptable salts which have been found useful in the treatment of nitric oxide synthase mediated diseases and disorders....
|
|
|
5869499 |
Benzyloxyquinuclidines as substance P antagonists
A compound of chemical formula (I) and its pharmaceutically acceptable salt: ##STR1## wherein X and Y are each hydrogen, halogen, C 1 -C 6 alkyl, halosubstituted C 1 -C 6 alkyl, C 1 -C 6 ...
|
|
|
5824677 |
Substituted amino alcohol compounds
Disclosed are compounds having a straight or branched aliphatic hydrocarbon structure of formula I: ##STR1## In formula I, n is an integer from one to four and m is an integer from four to twenty....
|
|
|
5817671 |
5-HT.sub.1F agonists
This invention provides 5-HT 1F agonists of Formula I: ##STR1## where A--B, X, and R are as defined in the specification. The invention also encompasses pharmaceutical formulations employing...
|
|
|
5767128 |
1,3-dihydro-2H-pyrrolo 2,3-b!pyridin-2-one compounds
The invention relates to a compound selected from those of formula (I): ##STR1## wherein R 1 , W and Y are as defined in the description, its geometric and/or optical isomers, and its...
|
|
|
5760034 |
Heterocyclic substituted naphthyridinones and methods and compositions employing them
Nitrogen-containing heterocyclic substituted naphthyridinones and methods and compositions employing such compounds are disclosed.
|
|
|
5750702 |
Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
The present invention encompasses structures of the formula: ##STR1## or the pharmaceutically acceptable non-toxic salts thereof wherein: ##STR2## wherein: W represents substituted or unsubstituted...
|
|
|
5747486 |
Thienopyridine or thienopyrimidine derivatives and their use
This invention provides an anti-inflammatory agent, particularly an agent for treating arthritis, and a bone resorption inhibiting agent, containing a thienopyridine or thienopyrimidine derivative...
|
|
|
5719135 |
Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
The present invention relates to compound of formula (I) ##STR1## wherein A is benzene, naphthalene, 5,6,7,8,-tetrahydronaphthalene, quinoline, isoquinoline, indole or 7-azaindole; R 1 is --H,...
|
|
|
5700757 |
Triazolopyridine dyes and intermediates therefor
Triazolopyridine dyes of the formula ##STR1## where R 1 is unsubstituted or substituted C 1 -C 20 -alkyl, unsubstituted or substituted phenyl, unsubstituted or substituted hydroxyl or...
|
|
|
5691356 |
Disubstituted heterocyclic thrombin inhibitors
Disubstituted heterocyclic thrombin inhibitors are provided which have the structure ##STR1## wherein G is ##STR2## wherein n is 0, 1 or 2 or 3; m is 0, 1, 2 or 3; Y is NH or S; p is 0, 1 or 2, Q...
|
|
|
5674878 |
Anellated dihydropyridines and the use thereof for the production of pharmaceutical preparations
Compound of general formula I ##STR1## wherein A is a benzo or thieno group; R 1 is (C 4 -6)cycloalkyl, (C 4 -6)cycloalkyl-(C 1 -5)alkyl or ##STR2## R 2 , m, R 3 , R 4 , R and u are defined as...
|
|
|
5663346 |
Substituted azaindolylidene compounds and process for their preparation
The present invention relates to compounds useful as tyrosine kinase inhibitors, having the following general formula (I) ##STR1## wherein one of the groups X 1 , X 2 , X 3 , X 4 is N and the...
|
|
|
5654298 |
Amine derivatives
This invention concerns novel aminopyridinium compounds of the formula I wherein R 1 , R 2 , R 3 , R 5 and R 6 are selected from the following combinations: ##STR1## (a) one of R 2 and R 6 is a...
|
|
|
5643922 |
Indole cyclohexyl platelet activating factor antagonists
The present invention provides compounds of formula ##STR1## and the pharmaceutically acceptable salts thereof which are potent antagonists of PAF and are useful in the treatment of PAF-related...
|
|
|
5641777 |
Substituted heterocyclic compounds and pharmaceutical compositions in which they are present
The invention relates to neurokinin receptor antagonist compounds of the formula ##STR1## in which: A is a divalent radical selected from: A 1 ) --O--CO-- A 2 ) --CH 2 --O--CO-- A 3 )...
|
|
|
5637595 |
Cyclic ether acetal PAF antagonists
Compounds of general formula (I), wherein W represents a 5- or 6-membered aromatic heterocyclic ring containing one or more non-quaternised sp2 nitrogen atoms in its ring, which heterocyclic ring...
|
|
|
5618819 |
1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-(3H)-one compounds
The invention relates to a compound selected from those of formula (I): ##STR1## wherein R 1 , W and Y are as defined in the description, its geometric and/or optical useful as anti-algies.
|
|
|
5616710 |
Triazolopyridine dyes
Triazolopyridine dyes of the formula ##STR1## where one of the two radicals A and E is nitrogen and the other is a radical of the formula C-R 1 , where R 1 is unsubstituted or substituted C 1 -C...
|
|
|
5614518 |
Morpholine derivatives as dopamine receptor subtype ligands
A class of substituted morpholine derivatives of formula ##STR1## wherein Y represents an optionally substituted bicyclic heteroaromatic ring system containing one or two nitrogen atoms, the ring...
|
|
|
5597916 |
1 substituted oxindoles and azaoxindoles
Compounds of Formula I have been shown to enhance the release of the neurotransmitter acetylcholine, and thus may be useful as chemical intermediates and as pharmacological agents in the treatment...
|
|
|
5593943 |
Heteroaromatically condensed hydroxypyridonecarboxamides, their preparation and use as herbicides
Heteroaromatically condensed hydroxypyridonecarboxamides of the structure I ##STR1## where the substituents and the ring Q have the following meanings: R 1 hydrogen, hydroxyl, substituted or...
|
|
|
5567711 |
Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
The present invention provides compounds of formula ##STR1## and the pharmaceutically acceptable salts thereof which are potent antagonists of PAF and are useful in the treatment of PAF-related...
|
|
|
5561146 |
Modified guanidino and amidino thrombin inhibitors
Thrombin inhibitors are provided which have the formula ##STR1## wherein Z is a thrombin inhibitor substructure containing distal and proximal binding site residues; and R 1 is cyano, hydroxyl,...
|
|
|
5554625 |
Substituted biphenylmethylimidazopyridines
Biphenylmethylimidazopyridines of the structure (I) are angiotensin (II) antagonists and therefore useful in the treatment of hypertension and related cardiovascular disorders and ocular...
|
|
|
5552090 |
Photochromic naphthopyran compounds
Described are novel reversible photochromic naphthopyran compounds, examples of which are compounds substituted at the 3 position of the pyran ring with (i) an aryl substituent and (ii) a phenyl...
|
|
|
5502187 |
Pharmaceutically active bicyclic-heterocyclic amines
The pharmaceutically active bicyclic heterocyclic amines (XXX) ##STR1## where W 1 is --N or --CH; W 3 is --N or --CH; W 5 is --N or --CR 5 -- with the proviso that W 5 is --CR 5...
|
|
|
5494916 |
Imidazo[4,5-C]pyridin-4-amines
Imidazo[4,5-c]pyridin-4-amines that induce interferon (α) biosynthesis in human cells. Also disclosed are pharmaceutical compositions containing such compounds and methods of inducing interferon...
|
|
|
5491161 |
Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives
Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives having the formula ##STR1## wherein n is 0 or 1; R 1 is hydrogen, nitro, amino, mono- or di(C 1 -6 alkyl)amino,...
|
|
|
5464781 |
Amino naphthyridine compounds as anti-rhoumatic agents
This invention relates to compounds of formula I and pharmaceutically acceptable salts thereof ##STR1## in which R 1 represents hydrogen, alkyl, hydroxy, carboxyalkenyl, alkoxycarbonyalkenyl,...
|
|
|
5457104 |
Quinolone- and naphthyridonecarboxylic acid derivatives
The invention relates to new quinolone- and naphthyridonecarboxylic acid derivatives which have hydrogen in the 6-position, to processes for their preparation, and to antibacterial compositions and...
|
|
|
5446153 |
Intermediates for imidazo[4,5-c]pyridin-4-amines
Imidazo[4,5-c]pyridin-4-amines that induce interferon (α) biosynthesis in human cells. Also disclosed are pharmaceutical compositions containing such compounds and methods of inducing interferon...
|
|
|
5438063 |
Imidazopyridines as angiotensin II antagonists
Novel imidazopyridine derivatives of formula I ##STR1## wherein ##STR2## and R 1 , R 2 , R 3 , R 4 , X and Y are as defined herein, and their salts, exhibit antagonistic properties toward...
|
|
|
5428035 |
1-substituted azaoxindoles and pharmaceutical compositions
Compounds of Formula I have been shown to enhance the release of the neurotransmitter acetylcholine, and thus may be useful as chemical intermediates and as pharmacological agents in the treatment...
|
|
|
5401736 |
4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid amide
Disclosed herein are 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid amide derivatives having a high antagonistic activity against angiotensin II and a high specificity to...
|
|
|
5378700 |
Fused pyrimidine derivative, process for preparation of same and pharmaceutical preparation comprising same as active ingredient
Disclosed is a fused pyrimidine of the formula [I] ##STR1## wherein R 1 , R 2 , and R 3 are as defined in the specification, Y represents a linking group of the formula ##STR2## wherein n is an...
|
|
|
5354749 |
Sulfonylbenzyl-substituted benzo- and pyridopyridones
Sulfonylbenzyl-substituted benzo- and pyridopyridones are prepared by reacting corresponding benzo- and pyridopyridones with sulphonylbenzyl compounds. The sulphonylbenzyl-substituted benzo- and...
|
|
|
5334719 |
Bicyclic(azaaromatic)indoles as inhibitors of leukotriene bisynthesis
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They...
|
|
|
5334598 |
Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
Phenoxyphenylacetic acids and derivatives of general structural formula I have endothelin ##STR1## antagonist activity and are therefore useful in treating cardiovascular disorders, such as...
|
|
|
5284661 |
Fused thiophene derivatives, their production and use
Novel fused thiophene derivatives of the formula (I): ##STR1## wherein W is ##STR2## R 1 and R 2 which may be same or different, are each independently hydrogen, halogen, cyano, nitro, acylamino,...
|
|
|
5273972 |
[(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
This invention provides novel 2-substituted-3-quinuclidinyl arylcarboxamides and arylthiocarboxamides and corresponding arylcarboxylates which have utility as therapeutic agents which exhibit...
|
|
|
5266576 |
N-myristoyl transferase inhibitors
The invention relates to a compound of formula (I): ##STR1## which can be used as N-myristoyltransferase inhibitors, in which R 1 represents hydrogen, substituted or unsubstituted (C 1 -C 6 )...
|
|
|
5262426 |
N,N'-cycloalkyl/alkyl carboxamide 4H-imidazo-[4,5-b]pyridine compounds as PAF antagonists
A class of N,N'-cycloalkyl/alkyl benzamides of certain 4H-imidazo[4,5-b]pyridine compounds is described for treating cardiovascular and immuno-inflammatory related disorders mediated by platelet...
|
|
|
5235050 |
Thiadiazolopyridines
The process according to the invention for the preparation of herbicidal pyridylsulfonylureas of the formula (I) ##STR1## in which R 1 to R 5 and X are as defined in claim 1 comprises the...
|
|
|
5223499 |
6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists
Substituted imidazo[4,5-b]pyridines of structural formula: ##STR1## are angiotensin II antagonists useful in the treatment of hypertension and congestive heart failure.
|
|
|
5204359 |
Insecticidally active nitro compounds
Insecticidally active nitro compounds of the formula ##STR1## wherein R 1 is hydrogen, cyano or alkyl, R 2 is hydrogen or an organic radical, R 3 is ##STR2## R 4 is an organic radical, R...
|
|
|
5200407 |
Azole derivatives and anti-ulcerative composition containing same
Compounds of the general formula (I): ##STR1## and pharmaceutically acceptable salts thereof, in which A, B, C and D each represent --CH or --N, with the proviso that at least one of them is...
|
|
|
5198434 |
Angiotensin II antagonizing fused pyridinyloxy containing derivatives
The invention concerns pharmaceutically useful compounds of the formula I, in which R 1 , R 2 , R 3 , R 4 , n, m, X, Y and Z have the various meanings defined herein, and their non-toxic salts, and...
|
|
|
5194605 |
Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs
Compounds of the formula ##STR1## are disclosed. These compounds inhibit the angiotensinogen-cleaving action of the natural proteolytic enzyme, renin, are useful in treating, preventing or managing...
|
|
|
5190938 |
Derivatives of 2-hydroxythiophene and -furan fused with a nitrogen-containing ring and their application in therapy
The invention relates to compounds of formula ##STR1## in which R 1 is selected from the groups R 3 and OR 3 , R is selected from H and a group CHR 2 R', in which R 2 is selected from H, alkyl,...
|